期刊文献+

复方甘草酸苷治疗儿童慢性荨麻疹疗效观察 被引量:1

Therapeutic effects of compound glycyrrhizin in treatment of children chronic urticaria
下载PDF
导出
摘要 目的评价复方甘草酸苷治疗儿童慢性荨麻疹的疗效和安全性。方法对45例慢性荨麻疹患者静脉滴注复方甘草酸苷40 m l,每日1次,疗程14 d,分别于治疗第7天和治疗第14天进行疗效观察。结果治疗第7天,症状总积分由治疗前的7.67±0.67下降到2.53±2.54;16例痊愈,12例显效,有效率为62.22%。治疗第14天时总积分进一步下降为1.49±2.02;21例痊愈,13例显效,有效率为75.56%。结论复方甘草酸苷治疗儿童慢性荨麻疹疗效肯定,安全性高。 Objective To evaluate the therapeutic effects of compound glycymhizin in the treatment of children chronic urticaria. Methods Forty-five patients were administrated with 40 ml compound glycyrrhzin once a day for 14 days, then clinical efficacy was evaluated at the 7th day and the 14th day. Results At the 7th day, the score of urticaria severity was declined from 7. 67±0. 67 to 2. 53±2. 54,16 patients being cured and 12 patients markedly improved. The effective rate was 62. 22%. At the 14 th day the score was further declined to 1.49±2. 02,21 Patients being cured and 13 patients markedly improved. The effective rate was 75. 56%. Conclusion Compound glycyrrhizin is an effective and safe drug in the treatment of children chronic urticaria.
出处 《中国厂矿医学》 2006年第6期488-489,共2页 Chinese Medicine of Factory and Mine
关键词 复方甘草酸苷 儿童 慢性荨麻疹 Compound glycymhizin Children Chronic urticaria
  • 相关文献

参考文献4

二级参考文献46

  • 1牛纪华,赵正举,牟乃洲,董元霞,姜淑君,朱发永.甘草甜素注射液治疗风湿性疾病的临床研究[J].山东中医杂志,1996,15(8):345-347. 被引量:6
  • 2徐向田 邹鲁贤.强力宁临床应用的进展.中国医院药学杂志,1989,(9):358-358.
  • 3[1]Takeda S,Ishthara K, Wakui Y, et al. Bioavailability study ofglycyrrhetic acid after oral administration of glycyrrhizin in rats;relevance to the intestinal bacterial hydrolysis[J].J PharmPharmacol,1996, 48(9):902.
  • 4[2]Van Rossum TG, Vulto AG, De Man RA, et al. Review article:glycyrrhizinas a potential treatment for chron-ic hepatitis C[J].Aliment Pharmacol Ther, 1998, 12(2):199.
  • 5[3]Van Rossum TG, Vulto AG, Hop WC, et al.Intraveno-us glycyrrhizin for the treatment of chronic hepatitis C:a double-blind, randomized, placebo controlled pha-se I/II trial[J]. J Gastroenterol Hepatol,1999, 14(11):1 093.
  • 6[4]Yamamura Y, Kotaki H, Tanaka N, et al. The pharmaco-kinetics of glycyrrhizin and its restorative effect on he-patic function in patients with chronic hepatitis and in chronicallycarbon-tetrachloride-intoxicated rats[J].Biopharm Drug Dispos, 1997, 18(8):717.
  • 7[5]Yamamura Y, Santa T, Kotaki H, et al. Administrationroute dependency of absorption of glycyrrhizin in rat-
  • 8[6]s:intraperitoneal administration dramatically enhancedbioavailability[J]. Biol Pharm Bull, 1995,18(2):337.
  • 9[7]Okamoto T, Tanaka N, Vulto AG, et al. The protectiveeffect of glycyrrhizin on anti-fas antibody-inducedhepatitis in mice[J]. Eur J Pharmacol, 2000, 387(2):229.
  • 10[8]Okamoto T, Kanda T, Vulto AG, et al. Glycyrrhizin protects mice fromconcanavalin A-induced hepatitiswithout affecting cytokine expression[J]. Int J Mol M-ecl, 1999, 4(2):149.

共引文献185

同被引文献9

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部